The Bluefield Project was established in 2010 to fund research directed towards curing frontotemporal dementia (FTD). Frontotemporal dementia is a devastating, early-onset degenerative brain disease and is recognized as a common cause of dementia in people under the age of 60 years. Often striking people in their prime, frontotemporal dementia is characterized by a progressive degeneration of the frontal portions of the brain, the regions responsible for language and behavior. Over the course of the disease, frontotemporal dementia patients may lose the ability behave appropriately, make judgments, communicate, and carry out daily activities. There are currently no treatments or cures for frontotemporal dementia, and generally patients die within ten years of diagnosis.
The Bluefield Project was founded by a family group whose lives have been directly impacted by frontotemporal dementia. Frustrated that there were no treatment prospects on the horizon for frontotemporal dementia, this family provided funds to the University of California, San Francisco to form the Consortium for Frontotemporal Dementia Research (CFR). The Bluefield Project intends to raise awareness and increase support to accelerate frontotemporal dementia research.